CrowdStrike and Palo Alto Networks hit record highs on Monday. Each rose more than 5%, after a week in which the Black Hat conference in Las Vegas turned into an argument about AI agents. CNBC’s Samantha Subin reported the move. CrowdStrike gained 11.3…
Patchy Mix weighed 140.8 pounds for a 134.5-pound limit at RIZIN 54 in Tokyo. He cannot be awarded a win, and the bout was demoted from co-main event.
OpenAI is recruiting a power-trading lead for its data centres. The role will own commodity hedging strategy across the company’s power portfolio. It will have no direct reports at first. Bloomberg’s Julian Hast reported the listing on Monday. OpenAI d…
Jefferies cut Apple from hold to underperform on Monday. That is the bank’s equivalent of a sell rating. It also cut its price target from $285.56 to $263.66. Fortune’s Sebastian Herrera reported the call. The bank’s supply-chain checks produced three …
A group of financial firms is working with Nvidia on a $500bn funding package for AI infrastructure. The group covers Apollo Global Management, Blackstone, BlackRock’s Global Infrastructure Partners, Brookfield Asset Management, Goldman Sachs and KKR. …
From 1 February 2027, a channel applying to the YouTube Partner Program will need 1,000 subscribers and 8,000 valid public watch hours over the previous 365 days. The current bar is 4,000 hours over 12 months. The Shorts route doubles as well. Twenty m…
Today, humanoid robots work in separate cages: a major limiting factor. Agility Robotics says Digit v5 will work cooperatively and safely with humans.
Mark Zuckerberg announced a $1 billion Future Is For Everyone Fund on Monday. It will invest directly in the American communities where Meta builds data centres. The commitment sits inside a 6,500-word letter, The Future is for Everyone: The Path to a …
Everyone seems to love a Liam Neeson action movie, good or bad, and now an actually good one is rising up the Netflix top 10 movie charts.
Two undisclosed deaths in Chinese gene-editing trials renew concerns about trial oversight, safety reporting, and transparency as gene therapy advances worldwide.